Oculus Innovative Sciences Launches Lasercyn(TM) into U.S. Dermatology Market for Use Following Laser Procedures, Microdermabrasions and Chemical Peels

PETALUMA, Calif., Aug. 30, 2016 (Healthcare Sales & Marketing Network) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions... Biopharmaceuticals, Dermatology, Product Launch Oculus Innovative Sciences, Lasercyn, ablative laser therapy, microdermabrasion
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news